Provided by Tiger Trade Technology Pte. Ltd.

JENSCARE-B

7.175
-0.125-1.71%
Volume:9K
Turnover:66.66K
Market Cap:2.99B
PE:-9.60
High:7.600
Open:7.600
Low:6.910
Close:7.300
52wk High:11.980
52wk Low:6.000
Shares:417.17M
HK Float Shares:310.31M
Volume Ratio:0.56
T/O Rate:0.00%
Dividend:- -
Dividend Rate:- -
EPS(LYR):-0.748
ROE:-19.02%
ROA:-10.11%
PB:3.41
PE(LYR):-9.60
PS:18.14

Loading ...

Jenscare Scientific Secures Hong Kong Approval for Heart Valve System

MT Newswires Live
·
Sep 07

Jenscare Says LuX-Valve Plus Wins Hong Kong Health Regulator Approval

Reuters
·
Sep 04

Jenscare Scientific Co - Lux-Valve Plus Receives Approval from Hong Kong Department of Health

THOMSON REUTERS
·
Sep 04

Revenue Surge Signals Commercial Turning Point as JENSCARE-B (09877) Leverages Innovation for Global Competition and Steadily Enhances Market Standing

Stock News
·
Sep 03

Jenscare Scientific (SEHK:9877) Stock Rallies Into A Steep Valuation Puzzle

Simply Wall St.
·
Sep 01

JENSCARE-B Posts Strong First-Half Results with 377.7% Revenue Surge

Stock News
·
Aug 31

Jenscare FY26 H1 Net Loss Narrows 71.4% to RMB 48.76 Million; Revenue Rises 377.7% to RMB 64.13 Million

Reuters
·
Aug 31

Jenscare Scientific Sets 31 Aug 2026 Board Meeting to Approve 1H26 Results and Potential Interim Dividend

Bulletin Express
·
Aug 19

Jenscare Scientific Schedules Board Meeting to Review Interim Results, Consider Dividend

Reuters
·
Aug 19

Jenscare Scientific Expects Revenue to Jump Up to 400% in H1

MT Newswires Live
·
Aug 10

JENSCARE-B (09877) Forecasts Mid-Year Revenue Surge of 385% to 400%

Stock News
·
Aug 10

Jenscare Scientific Co - Forecasts 2026 Interim Revenue of RMB63 Mln–RMB65 Mln, up 385%-400% Y/Y

THOMSON REUTERS
·
Aug 10

Jenscare Completes First Implants in FDA Pivotal Trial for Lux-valve Plus Tricuspid Valve System

Reuters
·
Jul 16

JENSCARE-B Shares Surge Following EU Regulatory Approval for Key Heart Valve System

Stock News
·
Jul 08

Jenscare Scientific Says Lux-valve Plus Obtains EU MDR CE Certification

Reuters
·
Jul 08

Jenscare Earns EU MDR CE Mark for LuX-Valve Plus, Strengthening Global Expansion of Tricuspid Valve Portfolio

Bulletin Express
·
Jul 08

Jenscare-B's LuX-Valve Plus Transvenous Tricuspid Valve Replacement System Secures EU MDR CE Certification

Stock News
·
Jul 08

Jenscare Says Lux-valve Plus Wins EU MDR CE Certification

Reuters
·
Jul 08

Jenscare Scientific Co - Lux-valve Plus Obtains EU Mdr Ce Certification

THOMSON REUTERS
·
Jul 08

JENSCARE-B Reports No Share Capital Changes in June; Public Float Remains Compliant

Bulletin Express
·
Jul 07